Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.385 USD | +1.74% | +0.22% | +147.78% |
03-22 | H.C. Wainwright Adjusts Price Target on Pyxis Oncology to $7 From $4, Maintains Buy Rating | MT |
03-21 | Health Care Up on Drug Sales Optimism -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+147.78% | 254M | |
+9.76% | 106B | |
+1.09% | 104B | |
+6.72% | 23.25B | |
-13.73% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.79% | 16.99B | |
+8.01% | 14.26B | |
+39.66% | 12.76B |
- Stock Market
- Equities
- PYXS Stock
- News Pyxis Oncology, Inc.
- Pyxis Oncology : Health Care Limping in Late Trade